We are among 150 signatories to this open letter led by @MSF_access, urging @GileadSciences to give up its exclusive rights on patents and regulatory and trial data in remdesivir. Monopoly-based patents regime in this could obstruct access to lifesaving treatment for #COVID19 twitter.com/MSF_access/sta…
21:51 - 31 Mar 2020